Table of Content

1 Study Coverage
1.1 RNAi for Therapeutic Product Introduction
1.2 Global RNAi for Therapeutic Outlook 2019 VS 2024 VS 2030
1.3 United States RNAi for Therapeutic Outlook 2019 VS 2024 VS 2030
1.4 RNAi for Therapeutic Market Size, United States VS Global, 2019-2030
1.4.1 The Market Share of United States RNAi for Therapeutic in Global, 2019-2030
1.4.2 The Growth Rate of RNAi for Therapeutic Market Size, United States VS Global, 2019 VS 2024 VS 2030
1.5 RNAi for Therapeutic Market Dynamics
1.5.1 RNAi for Therapeutic Market Trends
1.5.2 RNAi for Therapeutic Market Drivers
1.5.3 RNAi for Therapeutic Market Challenges
1.5.4 RNAi for Therapeutic Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global RNAi for Therapeutic Competitor Landscape by Company
2.1 Global RNAi for Therapeutic Market Size by Company
2.1.1 Top Global RNAi for Therapeutic Player Ranked by Revenue (2024)
2.1.2 Global RNAi for Therapeutic Revenue by Player (2019-2024)
2.2 Global RNAi for Therapeutic Concentration Ratio (CR)
2.2.1 RNAi for Therapeutic Market Concentration Ratio (CR) (2019-2024)
2.2.2 Global Top 3 and Top 6 Largest Players of RNAi for Therapeutic in 2024
2.3 Global RNAi for Therapeutic Business Distribution, Business Type
2.3.1 Global RNAi for Therapeutic Players, Headquarters and Distribution
2.3.2 Players RNAi for Therapeutic Business Type
2.3.3 Date of International Players Enter into RNAi for Therapeutic Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States RNAi for Therapeutic Market Size by Company
2.5.1 Top United States RNAi for Therapeutic Player s Ranked by Revenue (2024)
2.5.2 United States RNAi for Therapeutic Revenue by Player (2019-2024)
3 RNAi for Therapeutic Market Segment by Type
3.1 RNAi for Therapeutic Market Segment by Type
3.2 Global RNAi for Therapeutic Market Size by Type
3.3 United States RNAi for Therapeutic Market Size by Type
4 RNAi for Therapeutic by Market Segment Application
4.1 RNAi for Therapeutic Market Segment by Application
4.2 Global RNAi for Therapeutic Market Size by Application
4.3 United States RNAi for Therapeutic Market Size by Application
5 Global RNAi for Therapeutic Market Size by Region
5.1 Global RNAi for Therapeutic Market Size by Region: 2019 VS 2024 VS 2030
5.2 Global RNAi for Therapeutic Market Size in Value by Region (2019-2030)
5.2.1 Global RNAi for Therapeutic Revenue by Region: 2019-2024
5.2.2 Global RNAi for Therapeutic Revenue by Region: 2024-2030
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America RNAi for Therapeutic Market Size YoY Growth 2019-2030
6.1.2 North America RNAi for Therapeutic Market Facts & Figures by Country (2019-2030)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific RNAi for Therapeutic Market Size YoY Growth 2019-2030
6.2.2 Asia Pacific RNAi for Therapeutic Market Facts & Figures by Country (2019-2030)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe RNAi for Therapeutic Market Size YoY Growth 2019-2030
6.3.2 Europe RNAi for Therapeutic Market Facts & Figures by Country (2019-2030)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America RNAi for Therapeutic Market Size YoY Growth 2019-2030
6.4.2 Latin America RNAi for Therapeutic Market Facts & Figures by Country (2019-2030)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa RNAi for Therapeutic Market Size YoY Growth 2019-2030
6.5.2 Middle East and Africa RNAi for Therapeutic Market Facts & Figures by Country (2019-2030)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Enzon Pharmaceuticals (Santaris Pharma)
7.1.1 Company Details
7.1.2 Description and Business Overview
7.1.3 RNAi for Therapeutic Introduction
7.1.4 Enzon Pharmaceuticals (Santaris Pharma) RNAi for Therapeutic Revenue, Gross, and Gross Margin (2019-2024)
7.1.5 Enzon Pharmaceuticals (Santaris Pharma) Recent Development
7.2 University of Texas
7.2.1 Company Details
7.2.2 Description and Business Overview
7.2.3 RNAi for Therapeutic Introduction
7.2.4 University of Texas RNAi for Therapeutic Revenue, Gross, and Gross Margin (2019-2024)
7.2.5 University of Texas Recent Development
7.3 OncoGenex
7.3.1 Company Details
7.3.2 Description and Business Overview
7.3.3 RNAi for Therapeutic Introduction
7.3.4 OncoGenex RNAi for Therapeutic Revenue, Gross, and Gross Margin (2019-2024)
7.3.5 OncoGenex Recent Development
7.4 Isarna Therapeutics
7.4.1 Company Details
7.4.2 Description and Business Overview
7.4.3 RNAi for Therapeutic Introduction
7.4.4 Isarna Therapeutics RNAi for Therapeutic Revenue, Gross, and Gross Margin (2019-2024)
7.4.5 Isarna Therapeutics Recent Development
7.5 Astrazeneca (Ionis Pharmaceuticals)
7.5.1 Company Details
7.5.2 Description and Business Overview
7.5.3 RNAi for Therapeutic Introduction
7.5.4 Astrazeneca (Ionis Pharmaceuticals) RNAi for Therapeutic Revenue, Gross, and Gross Margin (2019-2024)
7.5.5 Astrazeneca (Ionis Pharmaceuticals) Recent Development
7.6 INSYS Therapeutics Inc
7.6.1 Company Details
7.6.2 Description and Business Overview
7.6.3 RNAi for Therapeutic Introduction
7.6.4 INSYS Therapeutics Inc RNAi for Therapeutic Revenue, Gross, and Gross Margin (2019-2024)
7.6.5 INSYS Therapeutics Inc Recent Development
8 Value Chain and Sales Channels Analysis
8.1 RNAi for Therapeutic Value Chain Analysis
8.2 RNAi for Therapeutic Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Legal Disclaimer